In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with ...

Purdue University-connected startup Molecular Intelligence supports research scientists in bioengineering, medical science ...

US official says Trump confident China will not invade Taiwan during his term The isothermal nucleic acid amplification technology market has evolved significantly due to the growing need for ...

She will explore the chemistry of modified nucleic acids using computational tools, shedding light on their role in biology, medicine, and nanotechnology. Don't miss this opportunity to gain insights ...

Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform ...

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins.

PNC-27 is a synthetic peptide composed of 32 amino acids. It is engineered to contain the MDM-2 binding domain of the tumor ...

Quantum-Si's next-gen protein sequencing tech and growth partnerships show promise, but high costs, financial risks, and ...

A new review published in Genes & Diseases on long non-coding RNAs (lncRNAs) highlights their critical role in the ...

Maravai LifeSciences Holdings, Inc.’s MRVI share price has surged by 10.86%, which has investors questioning if this is right ...

Johns Hopkins scientists have developed an mRNA “booster” as a potential new way to treat rare genetic diseases marked by too ...